From Genetic Engineering News, thoughts on the nature of fifty-year business cycles and where biotech is heading: "Combining the rapid advances currently being made in cell biology with genomics, proteomics, and nanotechnology, it may be possible, over the next decade, that scientists will be able to create and engineer artificial cells for generating new tissues, limbs, and organs. It may also be conceivable by 2030, when the biotechnology revolution reaches the end of its 50-year cycle, that the average life span of humans will reach 125 years, which would translate into todays 35-year-old adults being the equivalent of tomorrows 70-year-old adults. It may be a fact or just plain science fiction. Only time will tell."
Link: http://www.genengnews.com/current/article.aspx?cat=Wall%20$treet%20BioBeat&id=69